Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

The long and the short of it.

Petsko GA.

Genome Biol. 2010;11(12):145. doi: 10.1186/gb-2010-11-12-145. Epub 2010 Dec 23. No abstract available.

PMID:
21205280
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The 802 million dollars fallacy.

Hodgson J.

Nat Biotechnol. 2004 Sep;22(9):1076. No abstract available.

PMID:
15340464
[PubMed - indexed for MEDLINE]
3.

China's biotech experiments.

Hepeng J.

Nat Biotechnol. 2005 Dec;23(12):1472-3. No abstract available. Erratum in: Nat Biotechnol. 2006 Feb;24(2):220.

PMID:
16421994
[PubMed - indexed for MEDLINE]
4.

Fresh horizons South Korea.

Cyranoski D.

Nature. 2002 Dec 12;420(6916):4-5. No abstract available.

PMID:
12478244
[PubMed - indexed for MEDLINE]
5.

Bridging the gap in the German economy.

Schiermeier Q.

Nature. 2005 Aug 25;436(7054):1087. No abstract available.

PMID:
16127797
[PubMed - indexed for MEDLINE]
6.

How do you measure "success" in a biotechnology company?

Greetham EM.

Nat Biotechnol. 1998 May;16 Suppl:59-60. No abstract available.

PMID:
9591275
[PubMed - indexed for MEDLINE]
7.

Rising costs hold up drug discovery.

Miller HI.

Nature. 1998 Oct 29;395(6705):835. No abstract available.

PMID:
9804407
[PubMed - indexed for MEDLINE]
8.

Biotech companies adapt to big pharma mergers.

Niiler E.

Nat Biotechnol. 2000 May;18(5):487-8. No abstract available.

PMID:
10802607
[PubMed - indexed for MEDLINE]
9.

Growth in R&D investment holding up.

Chipman A.

Nature. 2009 Nov 19;462(7271):264. doi: 10.1038/462264a. No abstract available.

PMID:
19924181
[PubMed - indexed for MEDLINE]
10.

Biotech business Down Under.

Beckley C.

Nature. 2004 Jun 3;429(6991 Suppl):5-9. No abstract available.

PMID:
15175704
[PubMed - indexed for MEDLINE]
11.

Public biotech 98: the numbers.

Lähteenmäki R, Michael A, Marshall A.

Nat Biotechnol. 1999 May;17(5):429-32. No abstract available.

PMID:
10331795
[PubMed - indexed for MEDLINE]
12.

Profit at a cost?

[No authors listed]

Nat Cell Biol. 2000 Jul;2(7):E113. No abstract available.

PMID:
10878816
[PubMed - indexed for MEDLINE]
13.

When a long shot is worth a shot.

Jacobs T, Fischer J.

Nat Biotechnol. 2005 Jul;23(7):805. No abstract available.

PMID:
16003361
[PubMed - indexed for MEDLINE]
14.

Biotechnology mergers and acquisitions.

Champsi FH.

Nat Biotechnol. 1998 May;16 Suppl:61-2. No abstract available.

PMID:
9591276
[PubMed - indexed for MEDLINE]
15.

Biotechs hedge against big pharma givebacks.

Dorey E.

Nat Biotechnol. 1999 May;17(5):416-7. No abstract available.

PMID:
10331784
[PubMed - indexed for MEDLINE]
16.

Can personalized drugs pay off?

Stipp D.

Fortune. 2002 May 13;145(10):168. No abstract available.

PMID:
12025349
[PubMed - indexed for MEDLINE]
17.

Biotech R&D goes further afield.

Lawrence S.

Nat Biotechnol. 2006 Sep;24(9):1052. No abstract available.

PMID:
16964201
[PubMed - indexed for MEDLINE]
18.

Is there balm in Gilead?

Jacobs T.

Nat Biotechnol. 2006 Dec;24(12):1478. No abstract available.

PMID:
17160040
[PubMed - indexed for MEDLINE]
19.

Biotech bonanza.

Stipp D.

Fortune. 1999 Nov 8;140(9):333-4. No abstract available.

PMID:
10623111
[PubMed - indexed for MEDLINE]
20.

Angel investors shy away from biotech.

Bouchie A.

Nat Biotechnol. 2005 Jan;23(1):145. No abstract available.

PMID:
15706637
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk